Gene · 2021
NIH grants944
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 944
Download this page as JSON| Grant | Title | ENDOG papers | Newest fiscal year |
|---|---|---|---|
| R35GM119793 | Mitochondrial Stress Signal Transduction from Organelle to Organism | 1 | 2020 |
| RF1AG053391 | Physiology and Pathophysiology of Apolipoprotein E receptor-2 splicing in Alzheimer's disease | 1 | 2020 |
| T32ES007266 | Training Grant in Molecular Mechanisms of Toxicity | 1 | 2020 |
| R01AI079705 | Rab7 and estrogen-ER as B cell-intrinsic mediators of auto/antibody responses | 2 | 2019 |
| R01GM120005 | Host management of the mitochondrial genome | 2 | 2019 |
| R01HL079669 | Cell Priming, Receptor Cross-Talk, and Acute Lung Injury | 2 | 2019 |
| K22CA204458 | Cell survival by anastasis, a novel therapeutic target in cancer | 1 | 2019 |
| P01DA037830 | Dysregulation of metabolic and bioenergetic pathways by cocaine and HIV-1 in CNS | 1 | 2019 |
| P01HL028481 | Molecular Genetic Approaches in Atherosclerosis Research | 1 | 2019 |
| P50AG016573 | The Alzheimer's Disease Research Center at the University of California, Irvine | 1 | 2019 |
| R01AG035355 | ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal) | 1 | 2019 |
| R01AG038710 | The Role of Appoptosin in Alzheimer's Disease and Other Tauopathies | 1 | 2019 |
| R01AI114748 | miRNA-mediated premature T cell aging in vaccine failure during viral infection | 1 | 2019 |
| R01AI120698 | Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence. | 1 | 2019 |
| R01AT009152 | Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease | 1 | 2019 |
| R01CA185301 | Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention | 1 | 2019 |
| R01CA193698 | Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy | 1 | 2019 |
| R01DK041876 | Mechanisms of Liver Cell Injury | 1 | 2019 |
| R01DK104363 | DHA Reverses Gene Network Signatures of Fructose-induced Metabolic Syndrome | 1 | 2019 |
| R01EB018857 | Nanoparticle Fibrogenicity and Fibroblast Stem-Like Cells | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2021/grants?page=17